| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |